Jennifer Ashton, a board-certified OB-GYN and board-certified in obesity medicine, echoed Aronne, saying it's important to understand that obesity is a chronic condition
PlexusDx compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan is also affordable for out-of-pocket patients with no insurance required
The safety profile is broadly consistent with other GLP-1 receptor agonists already on the market
According to the latest financial report from Novo Nordisk, in 2025, the sales of semaglutide in Greater China are expected to reach approximately 5.4 billion Danish kroner, equivalent to about 6.7 billion RMB, of which the diabetes version generated approximately 5.645 billion RMB in sales, nearly seven times the approximately 835 million RMB generated by the weight-loss version
We recommend Beauty Insured as your indemnity provider